Literature DB >> 10844886

Appendiceal adenocarcinoma with ovarian metastases in the third trimester of pregnancy.

N J Sebire1, M Osborn, A Darzi, A Farthing, R D Goldin.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10844886      PMCID: PMC1297977          DOI: 10.1177/014107680009300410

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Hemorrhoidectomy with self-retaining retraction.

Authors:  H H Chen; J S Chen; C R Changchien; R Tang; J Y Wang
Journal:  Dis Colon Rectum       Date:  1996-09       Impact factor: 4.585

Review 2.  Zoster sine herpete, a clinical variant.

Authors:  D H Gilden; R R Wright; S A Schneck; J M Gwaltney; R Mahalingam
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

3.  Oral acyclovir in the treatment of acute herpes zoster ophthalmicus.

Authors:  L M Cobo; G N Foulks; T Liesegang; J Lass; J E Sutphin; K Wilhelmus; D B Jones; S Chapman; A C Segreti; D H King
Journal:  Ophthalmology       Date:  1986-06       Impact factor: 12.079

4.  Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.

Authors:  S Tyring; R A Barbarash; J E Nahlik; A Cunningham; J Marley; M Heng; T Jones; T Rea; R Boon; R Saltzman
Journal:  Ann Intern Med       Date:  1995-07-15       Impact factor: 25.391

  4 in total
  2 in total

1.  Management of Low-Grade Appendiceal Mucinous Neoplasm with Extensive Peritoneal Spread Diagnosed during Pregnancy: Two Case Reports and Literature Review.

Authors:  Ekaterina Baron; Vadim Gushchin; Mary Caitlin King; Andrei Nikiforchin; Armando Sardi
Journal:  Case Rep Oncol Med       Date:  2020-10-15

Review 2.  Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy.

Authors:  Erika Haase; Dal Yoo; Paul H Sugarbaker
Journal:  World J Surg Oncol       Date:  2009-05-19       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.